Introduction:
The prevalence of glucose intolerance in Bangladesh is 12.4% 1 . Diabetes is a fairly common medical complication of pregnancy associated with maternal, foetal and neonatal morbidities and mortalities. About 7% of all pregnancies are complicated by gestational diabetes mellitus (GDM) 2 comparable to 6.8% in Bangladesh reported by Sayeed et al 3 .The duration and severity of maternal diabetes and quality of control during pregnancy determine the outcome of pregnancy in terms of maternal and fetal morbidities.
Among the various metabolic consequences these (IDM) suffer, hypoglycemia is the commonest and most serious because of its association with both acute decompensation and long-term neuronal loss. 4 Most IDMs are prone to develop severe but asymptomatic hypoglycemia during the first postnatal hours 5 .
Hypoglycemia in IDMs is the result of maternal hyperglycemia in pregnancy and consequent foetal hyperglycemia and hyperinsulinemia. The normal plasma hormonal pattern of low insulin, low glucagon, and high catecholamines is reversed to a pattern of high insulin, low glucagon, and low epinephrine in IDMs. As a consequence of this abnormal hormone profile, endogenous glucose production is significantly inhibited compared with that in normal infants, thus predisposing them to hypoglycemia. 6 As hyperinsulinemic hypoglycemia is a major risk factor for brain injury and subsequent neurodevelopmental handicap, the identification, rapid diagnosis and prompt management of patients with or without hypoglycemia is essential if brain damage is to be avoided 7 .
Human C-peptide is a 31 amino acid chain and is secreted from the beta cells of pancreas in equimolar ratio with insulin. Cord serum levels of C-peptide are used as an index of fetal beta-cell function, rather than insulin levels, because degradation of insulin is increased in the presence of slight hemolysis. 8 In a previous study Kuhl et al 9 reported that IDMs who became hypoglycemic at 2 hours of life had significantly higher levels of glucose and immunoreactive insulin in cord blood than IDMs who remained normoglycemic. Metzer B E et al 10 also found that frequency of neonatal hypoglycemia was higher with higher cord C-peptide levels and newborns with hypoglycemia tended to have a higher frequency of cord C-peptide levels of more than 90 th percentile.
So umbilical cord C-peptide levels provide direct indication of endogenous fetal levels of insulin and could predict hypoglycemia in early neonatal life.
Materials and methods:
This case-control study was carried out in the department of Obstetrics and Gynecology, and Special Care Baby Unit (SCABU) at BIRDEM. (Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders).
Sixty neonates born to diabetic mothers during November 2004 through February 2005 were studied. IDMs with major congenital malformation at birth, severe perinatal asphyxia and severe erythroblastosis foetalis were excluded from study. Neonates were screened for blood glucose at 4, 6, 8, 12, 18, 24 hours of postnatal age as per existing routine SCABU schedule irrespective of feeding status. Thirty infants who developed hypoglycemia at any time during the first 24 hours of age were considered as cases. Another 30 infants who did not develop hypoglycemia during the first 24 hours were considered as controls. Blood glucose value of < 2.6 mmol/l was considered as neonatal hypoglycemia 4 . Cord blood samples for estimation of C-peptide level were collected during delivery from baby side taking 2 ml blood in plain test tube. The samples were centrifuged, and serum was separated and stored at -20°C before assay by chemiluminescence ELISA using IMMULITE 2000, USA. Blood glucose level of IDMs was measured by Precision-plus (MediSense, USA) glucometer using glucose oxidase method at birth in cord blood, and thereafter at bed side blood sample obtained from heelprick. Results were analyzed by using Statistical Package for Social Science (SPSS Version 11.0) software package. Informed consent were taken from parents. It was clearly communicated that no additional blood sample would be collected, no extra procedures would be done and no modification of treatment plan would be made. Hypoglycemia was detected by 6 hours of age in majority of cases (73.3%). Tanzer et al 15 reported the lowest blood glucose values in healthy infants during first 3 hours, at 2 hours by Robert S et al 13 given the emphasis that glucose monitoring in IDMs need only be done in first 2 hours of life ,We did not examine the blood glucose at 2 hours and glucose level was done irrespective of feeding status, as we followed the existing SCABU protocol. Probably it would have been more frequent or severe if glucose estimation could have been done prefeed and also at 2 hours of life.
Results:
Maayan-Metzer et al 16 studied pre-feed glucose values of 280 IDMs, where 48.6% developed mild to moderate hypoglycemia (2.2 to 2.5 mmol/l and 1.7 to 2.1 mmol/ l) and 4% severe hypoglycemia (<1.7 mmol/l).The normal adaptation of this physiological hypoglycemia also demands early feeding to prevent severe hypoglycemia. Of the 30 hypoglycemic babies majority (93.3%) were asymptomatic.The predominance of asymptomatic hypoglycemia in our study consistent with previously reported studies 12, 13
Fig.-1: Graph showing blood glucose status over 24 hours of postnatal age
However, the absence of overt symptoms at low blood glucose levels does not rule out central nervous system injury 17 . Neonatal hypoglycemia is associated with poor psychoneurological outcome. Evidence suggests that blood glucose should be maintained above 2.6 mmol/l to ensure normal neural function in infants irrespective of the presence or absence of abnormal clinical signs 18 .
Babies born to diabetic mothers are hyperinsulinemic and the neonatal hypoglycemia seems to result from this together with a delay in increasing plasma glucagon levels 5 . C-peptide which provides an indication of insulin secretion is directly related to the severity of maternal diabetes, significantly associated with neonatal complications including hypoglycemia 10, 19 In the present study C-peptide values in majority of cases (66.7%), whereas 40% of controls were above normal values indicates raised level even in strict metabolic control done in this specialized centre during pregnancy.
The mean value of cord blood C-peptide in IDMs who became hypoglycemic is ( 4.57 ± 2.5 ) higher than in IDMs who remained normoglycemic ( 2.81± 2.1 ) which is statistically significant (P = 0.005). Similar finding also reported by Abdelgadir et al 20 , Goudard et al 21 , Fallucca F et al 22 . This significant difference of mean C-peptide value means that there may be an association between high C-peptide and risk of hypoglycemia in IDMs.
IDMs are markedly hyperinsulinemic at birth and that ambient hyperinsulinemia plays a crucial role in the development of foetal macrosomia and neonatal hypoglycemia 23 .Metzer BE et 10 al in his study reported that biochemical and clinical hypoglycemia were strongly associated with elevated cord serum C-peptide levels but weakly related to maternal OGTT glucose measurements.
We have also examined the relationship of blood glucose values of all IDMs with cord C-peptide levels which showed significant inverse relation (r value -0.326 p value .011). This finding is comparable with others studies that reported cord C-peptide levels were found to be inversely related to blood glucose concentration in early postnatal period 10, 21, 22 . But Mohajeri Tehrani et al 24 and Stenninger E et al 25 found association between cord C-peptide and macrosomia in IDMs but not with hypoglycemia.
The significant correlation of increased cord blood insulin with neonatal hypoglycemia in IDMs being observed by Dawid G et al 26 and Knip et al 23 . As Cpeptide secreted in equimolar concentration with insulin, so this high insulin levels also represent the high C-peptide at the same time. Similar observation has also been reported by Cooper et al 27 . So there is significant association of high cord C-peptide and postnatal hypoglycemia.
Conclusion:
Raised level of cord blood C-peptide is significantly associated with early postnatal hypoglycemia in babies born to diabetic mothers.
Recommendation:
Neonatal hypoglycemia has been linked to poor neurodevelopmental outcome. Increased prevalence of asymptomatic neonatal hypoglycemia in IDMs stress the importance of systematic glucose monitoring at risk babies to prevent severe and recurrent hypoglycemia.
Limitation of the study
Sample size is small, needs further study with a larger sample size, specially size of control which should be at least 1.5 times of cases.
C-peptide is not a routine test, fairly costly.
